NCT03622788 2025-12-17Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell TransplantM.D. Anderson Cancer CenterPhase 1/2 Active not recruiting16 enrolled
NCT02061800 2024-06-04CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell TransplantColumbia UniversityPhase 1/2 Active not recruiting14 enrolled
NCT00056966 2012-06-29Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological DiseasesBaylor College of MedicinePhase 1/2 Completed24 enrolled